The estrogen–ECM–integrin– cytoskeleton axis in pelvic organ prolapse: a mechanobiological framework linking matrix remodeling to repair failure
Frontiers in Bioengineering and Biotechnology · 02.11.2026 · 14
DOI: 10.3389/fbioe.2026.1949172 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 02.11.2026. Verfasst von Xiaoyue Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong Universi…. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pelvic organ prolapse (POP) is a common disorder of pelvic support, but its estimated prevalence depends strongly on ascertainment. A 2024 meta-analysis reported a pooled prevalence of 30.9%, increasing to 41.8% in examination-based studies. Altered collagen turnover and estrogen-responsive tissue remodeling are important features of POP, yet they do not fully explain how extracellular-matrix (ECM) abnormalities may become persistent defects in cellular force transmission and repair. This narrative Review develops an evidence-graded estrogen–ECM–integrin–cytoskeleton axis, organized around ECM mechanics and fibroblast mechanosensing. We distinguish ERα-, ERβ- and GPER-mediated signaling; indirect hormonal effects on the matrix presented to integrins; and the more limited evidence for direct hormonal control of integrin signaling in human POP. We examine LOX/LOXL-dependent matrix maturation while separating expression, catalytic activity and mature cross-link measurements. The integrin–talin–vinculin molecular clutch provides a candidate connection between abnormal matrix resistance, FAK/Src–RhoA/ROCK signaling, cytoskeletal function and YAP/TAZ-dependent transcription. However, POP-associated mechanics vary with tissue compartment, measurement scale and disease state. Reduced counter-resistance and clutch slippage therefore represent a testable scenario, not a universal disease sequence. We identify experiments that could distinguish matrix-mediated effects from intrinsic fibroblast dysfunction and connect these questions to biomaterial design, controlled loading and local pathway modulation. Clinical estrogen therapy and experimental mechanopharmacology must remain distinct: improved local tissue quality does not establish prevention of prolapse recurrence, and no YAP/TAZ-targeted drug is approved for POP.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
- Shanghai Key Laboratory of Embryo Original Diseases, Shanghai, China.
Zitieren
APA
Yang, X., Chen, L., Wang, X., Zhu, M., Chen, Z., Zheng, X., & Lin, Q. (2026). The estrogen–ECM–integrin– cytoskeleton axis in pelvic organ prolapse: a mechanobiological framework linking matrix remodeling to repair failure. Frontiers in Bioengineering and Biotechnology, 14. https://doi.org/10.3389/fbioe.2026.1949172
Vancouver
Yang X, Chen L, Wang X, Zhu M, Chen Z, Zheng X, et al. The estrogen–ECM–integrin– cytoskeleton axis in pelvic organ prolapse: a mechanobiological framework linking matrix remodeling to repair failure. Frontiers in Bioengineering and Biotechnology. 2026;14. doi:10.3389/fbioe.2026.1949172
BibTeX
@article{Yang2026,
author = {Yang, Xiaoyue and Chen, Lan and Wang, Xiaohan and Zhu, Minjiao and Chen, Zheng and Zheng, Xuan and Lin, Qin},
title = {The estrogen–ECM–integrin– cytoskeleton axis in pelvic organ prolapse: a mechanobiological framework linking matrix remodeling to repair failure},
journal = {Frontiers in Bioengineering and Biotechnology},
year = {2026},
volume = {14},
doi = {10.3389/fbioe.2026.1949172}
}
EUVIMED